Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion description "[The IGF1 19 CA repeat polymorphism interacted with hormone replacement therapy (HRT) among NHW post-menopausal women; women who had the 19/19 IGF1 genotype were at reduced risk of breast cancer (OR 0.64, 95% CI 0.47-0.88) if they did not use HRT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion evidence source_evidence_literature NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion SIO_000772 17051426 NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion wasDerivedFrom befree-2016 NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_assertion wasGeneratedBy ECO_0000203 NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.
- befree-2016 importedOn "2016-02-19" NP575159.RAtC-4o45VKHVJF1C4AU5TctjfAbDav-shHl1X_kbTZ0A130_provenance.